The Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC) plans to launch a number of dedicated epigenetics funding opportunities over the next several years. Please refer back to this page for updates.
Team Grant: CEEHRC Phase II (Phase 2: Full Application)
Team Grant: CEEHRC Phase II (Phase 1: Letter of Intent)
The overarching objective of the CEEHRC Team Grant funding is to enhance the translation of epigenetics research to health benefits.
The goal of this program is to support collaborative research teams that have the capacility to transform epigenetics research, enhance our understanding of gene-environment interactions, address major health research questions (including health services/policy/economic/ethical, legal or social issues), and foster the application of knowledge gained to the clinic and/or to populations.
As part of their commitment to the Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC), the CIHR Institute of Neurosciences, Mental Health and Addiction (INMHA) has launched a Priority Announcement in Epigenetics on the Fall 2011 Fellowship funding opportunity. CIHR-INMHA will provide funding for an application that supports research in epigenetics relevant to human health and disease.
This Funding Opportunity is to support the development of a National Epigenomics Platform, comprised of several Epigenomic Mapping Centres (EMCs) and one Epigenomic Data Coordination Centre (EDCC). It is expected that these centres will form key nodes of the larger CEEHRC initiative.
One of the main goals of the CEEHRC Epigenomic Mapping Centres (EMCs) is the systematic high-resolution mapping of human epigenomic marks in appropriate cell/tissue types.
This Funding Opportunity targets existing genome sequencing centres across Canada, where there is already a critical mass of genomic research expertise and platforms for genomic mapping available for direct application to epigenomics research.
- Epigenomic Mapping Centres (EMC) Funding decision
- Epigenomic Data Coordination Centre (EDCC) Funding decision
This Funding Opportunity is to support the development of innovative new technologies and approaches that have the potential to transform how epigenetics research is performed. This may include small scale projects for the identification and validation of new epigenetic marks and related compounds (e.g. antibodies, chemical markers, etc), the development of appropriate tools to discover and monitor epigenetic changes, and research into the mechanisms underlying the heritability of epigenetic marks.
It is expected that the outcomes of this Catalyst Grant Funding Opportunity will inform other activities of the CEEHRC initiative, including potentially the Epigenomic Mapping Centres (EMCs) funded through the CEEHRC Epigenomics Platform.
- Date modified: